Thanks to Professor Dreyfuss for this invitation and to Professor Rutschman for her thought-provoking paper. Professor Rutschman is deeply engaged with the law of pharmaceutical innovation. And she is also deeply committed to a public health perspective. For many reasons, the two domains often speak past each other. Her paper provides a basis for shared vocabulary if not a common language.